Mecasermin0 vendors competing
No vendor pricing available for this peptide yet.
Research details
Mecasermin — research data
Regulatory statusFDA-approved (Increlex)
NCAA D1Banned
Overview
About Mecasermin
Mechanism of action
Recombinant human IGF-1; stimulates linear growth
Safety profile
Hypoglycemia, intracranial hypertension, acromegaly features · FDA-approved for IGF-1 deficiency; hypoglycemia risk; intracranial hypertension rare
Related pages